相关实验视频
Updated: Jan 13, 2026

05:53
Use of a Hanging-weight System for Liver Ischemia in Mice
Published on: August 7, 2012
16.4K
肝细胞衍生外体通过抑制补充激活来减少肝缺血-再输液 (IR) 损伤
Zhi Yang1,2,3,4, Bin Deng1,2,3,4, Tian Sun1,2,3,4
1Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, The First Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, China.
Frontiers in bioscience (Landmark edition)
|January 8, 2026
概括
肝细胞衍生外体通过抑制补体激活来减轻肝损伤. 这些专门的囊泡提供了一种新的治疗策略,用于预防肝脏缺血-再输液损伤 (IRI).
科学领域:
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 外体是细胞间通信的关键媒介.
- 肝细胞衍生外体显示出作为肝脏疾病的生物标志物和治疗剂的潜力.
- 它们在肝损伤和再生中的作用是一个活跃的研究领域.
研究的目的:
- 研究肝细胞衍生外体在减轻肝脏缺血-再输液损伤 (IRI) 的治疗潜力.
- 阐明这些外体体具有保护作用的潜在机制.
主要方法:
- 肝脏IRI的小鼠模型被用于评估肝细胞衍生外体的效应.
- 生物化学标志物 (ALT,AST,LDH) 和炎症性细胞因子被测量.
- 分析了肝细胞亡,炎症细胞透和补体激活 (C3d).
- 通过使用Annexin V,研究了外体细胞融合的作用.
主要成果:
- 与PBS相比,使用肝细胞衍生外体的治疗显著降低了肝损伤标志物 (ALT,AST,LDH).
- 外体抑制了肝细胞亡,降低了炎症性细胞因子水平,并减少了炎症细胞透.
- 补充激活,通过降低C3d表达来表示,被外体抑制.
- 阻断外体细胞融合减少了保护作用.
结论:
- 肝细胞衍生外体通过抑制补体激活,有效地减轻肝脏IRI.
- 这项研究揭示了一种新的外体细胞功能机制,用于阻断补体通路.
- 外体体是预防肝脏IRI的有希望的治疗途径.
相关概念视频
Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K

